Arca
Skip to content
Tools
Tools

Gram-positive bacterial infection

Drug research and approvals for gram-positive bacterial infection: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 22, 2026, 280 studies of gram-positive bacterial infection are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 280
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 280 recruiting on ClinicalTrials.gov ↗

How its trials ended

44 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 14 whose ending is known, 36% met their primary endpoint, 7% missed it and 57% stopped early.

  • Completed, result not reported2045%
  • Met its primary endpoint511%
  • Ongoing511%
  • Status unknown511%
  • Stopped: other or unclear49%
  • Stopped: enrollment or feasibility25%
  • Stopped: sponsor or business decision25%
  • Missed its primary endpoint12%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.